share_log

Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $144

Benzinga ·  Apr 25 14:36

Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $138 to $144.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment